Aurora CO 血液癌症临床试验
8项针对 血液癌症的研究正在 Aurora及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
招募中3 期
- University of Colorado Cancer Center ( Site 0021), Aurora
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
招募中观察性研究
- Children's Hospital Colorado, Aurora
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
招募中3 期
- University of Colorado, Aurora
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中观察性研究
- Children's Hospital Colorado, Aurora
- University of Colorado Hospital, Aurora
Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
招募中观察性研究
- Childrens Hospital of Colorado, Aurora
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
招募中3 期
- Children's Hospital Colorado, Aurora
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
招募中1 期
- University of Colorado, Aurora
其他城市的 血液癌症试验
- Houston, TX46 项研究
- New York City, NY26 项研究
- Boston, MA25 项研究
- Washington, DC19 项研究
- Baltimore, MD18 项研究
- Seattle, WA18 项研究
- Los Angeles, CA17 项研究
- Durham, NC16 项研究
- Chicago, IL15 项研究
- Philadelphia, PA14 项研究
- Atlanta, GA13 项研究
- Nashville, TN13 项研究
Aurora的其他研究
- 癌症（所有类型）35 项研究
- 结直肠癌32 项研究
- 非小细胞肺癌30 项研究
- 乳腺癌27 项研究
- 转移性癌症25 项研究
- 卵巢癌25 项研究
- 1型糖尿病23 项研究
- 肥胖症21 项研究
- 肺癌19 项研究
- 前列腺癌19 项研究
- 心力衰竭18 项研究
- 黑色素瘤18 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。